Essais liés3clinical trials
VilleSanta Monicalocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT03235479

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
Rimegepant Migraine Phase 3 NCT03235479 Safety and Efficacy Study in Adult Subjects With Acute Migraines COMPLETED
NXN-188 Migraine Phase 2 NCT00920686 Study of NXN 188 for the Treatment of Migraine With Aura COMPLETED
Rimegepant Migraine Phase 2/3 NCT03266588 Open Label Safety Study in Acute Treatment of Migraine COMPLETED